From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
FUB-144 structure.png
Legal status
Legal status
CAS Number
PubChem CID
Chemical and physical data
Molar mass349.449 g·mol−1
3D model (JSmol)

FUB-144 (also known as FUB-UR-144) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is an analogue of UR-144 and XLR-11 where the pentyl chain has been replaced with fluorobenzyl.

Legal status[edit]

In the United States, FUB-144 became a Schedule I Controlled Substance in 2019.[2]

Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.[3]

See also[edit]


  1. ^ "FUB-144". Southern Association of Forensic Scientists. Archived from the original on 27 September 2015. Retrieved 23 July 2015.
  2. ^ "Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I". Federal Register.
  3. ^ "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.